262 related articles for article (PubMed ID: 30894904)
1. Evaluation of
Novotni G; Jakimovska M; Plaseska-Karanfilska D; Tanovska N; Kuzmanovski I; Aleksovski V; Karanfilovik K; Baneva-Dolnenec N; Stankovic M; Milutinovik M; Iloski S; Isjanovska R; Blazevska-Stoilkovska B; Duma A; Novotni A
Open Access Maced J Med Sci; 2019 Feb; 7(4):516-520. PubMed ID: 30894904
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid biomarkers for Alzheimer's disease: the role of apolipoprotein E genotype, age, and sex.
Mehrabian S; Alexopoulos P; Ortner M; Traykov L; Grimmer T; Kurz A; Förstl H; Bickel H; Diehl-Schmid J
Neuropsychiatr Dis Treat; 2015; 11():3105-10. PubMed ID: 26719695
[TBL] [Abstract][Full Text] [Related]
3. Correlation of polymorphism of APOE and LRP genes to cognitive impairment and behavioral and psychological symptoms of dementia in Alzheimer's disease and vascular dementia.
Mou C; Han T; Wang M; Jiang M; Liu B; Hu J
Int J Clin Exp Med; 2015; 8(11):21679-83. PubMed ID: 26885125
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E genotype in sporadic early- and late-onset Alzheimer's disease.
Masullo C; Daniele A; Seripa D; Filippini V; Gravina C; Carbone G; Gainotti G; Fazio VM
Dement Geriatr Cogn Disord; 1998; 9(3):121-5. PubMed ID: 9621997
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
[TBL] [Abstract][Full Text] [Related]
6. Potential Modifying Effect of the
Valdez-Gaxiola CA; Maciel-Cruz EJ; Hernández-Peña R; Dumois-Petersen S; Rosales-Leycegui F; Gallegos-Arreola MP; Moreno-Ortiz JM; Figuera LE
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958671
[TBL] [Abstract][Full Text] [Related]
7. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
[TBL] [Abstract][Full Text] [Related]
8. Age and sex differences in the association between APOE genotype and Alzheimer's disease in a Taiwan Chinese population.
Huang LC; Lee MY; Chien CF; Chang YP; Li KY; Yang YH
Front Aging Neurosci; 2023; 15():1246592. PubMed ID: 37680541
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of risk factors on the cognitive trajectory of early- and late-onset Alzheimer's disease.
Kim J; Woo SY; Kim S; Jang H; Kim J; Kim J; Kang SH; Na DL; Chin J; Apostolova LG; Seo SW; Kim HJ
Alzheimers Res Ther; 2021 Jun; 13(1):113. PubMed ID: 34127075
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
11. The synergistic risk effect of apolipoprotein ε4 and DNA (cytosine-5-)-methyltransferase 3 beta (DNMT3B) haplotype for Alzheimer's disease.
de Bem CM; Pezzi JC; Borba EM; Chaves ML; de Andrade FM; Fiegenbaum M; Camozzato A
Mol Biol Rep; 2016 Jul; 43(7):653-8. PubMed ID: 27188425
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of Proinflammatory Cytokines in Relation to APOE Epsilon 4 and Risk of Alzheimer's Disease in the Lithuanian Population.
Pšemeneckienė G; Petrikonis K; Rastenytė AD
Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31618972
[No Abstract] [Full Text] [Related]
13. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
[TBL] [Abstract][Full Text] [Related]
14. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
Wattmo C; Wallin ÅK
Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
[TBL] [Abstract][Full Text] [Related]
15. Association between the APOE
Montufar S; Calero C; Vinueza R; Correa P; Carrera-Gonzalez A; Villegas F; Moreta G; Paredes R
Int J Alzheimers Dis; 2017; 2017():1059678. PubMed ID: 29348964
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R
Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827
[TBL] [Abstract][Full Text] [Related]
17. Interplay between the APOE Genotype and Possible Plasma Biomarkers in Alzheimer's Disease.
Zverova M; Kitzlerova E; Fisar Z; Jirak R; Hroudova J; Benakova H; Lelkova P; Martasek P; Raboch J
Curr Alzheimer Res; 2018; 15(10):938-950. PubMed ID: 29852871
[TBL] [Abstract][Full Text] [Related]
18. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
19. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
